Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents Post author:Sam Post published:November 21, 2017 Post category:BioPharma Genentech is claiming that Pfizer’s proposed biosimilar infringes 40 of its patents. Source: BioSpace You Might Also Like Stealth Biotherapeutics Release: Company Announces New Appointments To Senior Leadership Team January 18, 2017 Bay Area???s Dynavax Shifts Focus to Immune-Oncology, Cuts 40% of Staff March 12, 2017 Seattle Genetics Commences Dosing in Early-Stage Multiple Myeloma Trial March 6, 2018
Stealth Biotherapeutics Release: Company Announces New Appointments To Senior Leadership Team January 18, 2017
